1、抗病毒治疗。美国食品和药物管理局（FDA）已授权使用抗病毒药物治疗轻度至中度COVID-19中较易患重病的患者。2、抗病毒治疗特异性作用病毒特定部分，阻止病毒在体内繁殖，有助于预防严重疾病和死亡。3、美国国立卫生研究院（NIH）为医疗服务提供者提供了《COVID-19 Treatment Guidelines》，帮助他们与患者合作，并...
接种Covid-19疫苗未能消除SARS-CoV-2感染风险,但接种疫苗可以显著降低与Covid-19相关的发病率和死亡率,尤其是那些有可能发展为严重疾病的高危人群。对于那些因免疫功能低下或接受免疫抑制药物治疗而无法对Covid-19疫苗产生足够反应的人群...
接种Covid-19疫苗未能消除SARS-CoV-2感染风险,但接种疫苗可以显著降低与Covid-19相关的发病率和死亡率,尤其是那些有可能发展为严重疾病的高危人群。对于那些因免疫功能低下或接受免疫抑制药物治疗而无法对Covid-19疫苗产生足够反应的人群,在omicron变异株流行之前,可以使用抗SARS-CoV-2单克隆抗体作为暴露前预防(PrEP)...
Infectious Diseases Society of America (IDSA) Management Guidelines CDC Sample Collection and Testing Guidelines for COVID-19 Thromboembolism Prevention and Treatment Interim Guidance for Managing Healthcare Personnel with SARS-CoV-2 Infection or Exposure to SARS-CoV-2 by the CDC Guidance for Hospitals...
目前美国疾病预防和控制中心(CDC)对MIS-A病例的定义是:患者年龄≥21岁,住院时间≥24小时,或患有致死性疾病,并符合一定的临床和实验室标准。患者可排除其他致死性疾病诊断(例如细菌性败血症、慢性疾病恶化)。 Covid-19诱发心脏功能障碍(包括心肌炎) 在因Covid-19住院的成年患者中,高达24%的患者出现心脏损伤或功能...
The CDC has resources on global COVID-19 on its website. For more information on investigational drugs and biologics being evaluated for COVID-19, see Treatment of Coronavirus Disease 2019 (COVID-19): Investigational Drugs and Other Therapies. See the article Coronavirus Disease 2019 (COVID-19...
7.没有足够的数据来建议或反对常规使用体外膜氧合治疗难治性低氧血症的COVID-19患者(BIII)。这可能与美国疫情动态有关,尚无足够病例证明其有效性与应用指证。 参考文献: 1.Coronavirus Disease 2019(COVID-19)Treatment Guidelines,NIH,April 21, 2020 ...
https://www.covid19treatmentguidelines.nih.gov/ 3. Bonow RO, Fonarow GC, O’Gara PT, Yancy CW. Association of Coronavirus Disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol. 2020;5(7):751-753. doi:10.1001/jamacardio.2020.1105PubMedGoogle ...
In concert with clinician judgment regarding patient presentations compatible with COVID-19, CDC guidelines prioritize patients from defined populations for further evaluation and testing as persons under investigation (PUI) (Table 3). These criteria are not exhaustive, and patients with an unestablished...
Coronavirus (SARS-CoV-2), the cause of COVID-19, a fatal disease emerged from Wuhan, a large city in the Chinese province of Hubei in December 2019. The World Health Organization declared COVID-19 as a pandemic due to its spread to other countries inside